Skip to main content
Caplight Logo









Ejenta

Ejenta

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.ejenta.com/

Last Round

Grant

Dec 18, 2024

Total Funding Raised

$1.77M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ejenta is a healthtech company that provides an AI-powered intelligent agent platform for remote health monitoring, using technology originally developed for NASA.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Health IoT, Patient Engagement, NLP & Conversational AI, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringintelligent agentsRPMconnected caremedical AIchronic condition managementvirtual carepredictive analyticsreadmission reductionpatient engagementpayer solutionsNASA technologyhealth IoTclinical decision supportastronaut health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ejenta Comparables

Compare Ejenta with similar companies based on industry and business-model similarity.

Ejenta comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HealthSnap
77%
Health Recovery Solutions
76%
Optimize Health
75%

Ejenta Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 18, 2024
AcceleratorJan 23, 2023
VC RoundJun 10, 2021
AcceleratorOct 29, 2020
AcceleratorJul 24, 2019
Accelerator
Jan 16, 2019

Key People

Founding team and executive leadership

Rachna Dhamija

Founder And CEO

Founding Team

Ejenta Investors

Notable investors and investment history

Ejenta investors
InvestorRounds
Winrock InternationalAccelerator
nvp capitalAccelerator
TechstarsAccelerator
Ignite Healthcare NetworkAccelerator
Wavemaker Three-Sixty HealthAccelerator
University of Arkansas for Medical SciencesAccelerator
BioVentures InvestorsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 77% MoM.

  • Jan 21, 2026

    Monthly visitors increased 40% MoM.

Ejenta Filings

Explore SEC and related filing metadata, where available.

Ejenta filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ejenta's valuation, stock price, and market status.

Is Ejenta a public or private company?

Ejenta is a private company.

What is the current stock price of Ejenta?

Ejenta is a private company with no public stock price. No recent secondary market data is available.

How much is Ejenta worth (valuation)?

Valuation information for Ejenta is not publicly available.

Can I buy Ejenta stock?

Ejenta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ejenta's last funding round?

Ejenta's most recent funding round was Grant on December 18, 2024.

Who are the main investors in Ejenta?

Key investors in Ejenta include nvp capital, 15th Rock.

Will Ejenta IPO soon?

No public IPO plans have been announced for Ejenta.

How can I track Ejenta secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ejenta's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year Founded2012
Last FundingDec 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?